FFCP PHASE1:Mm9::chr10:61715859..61715869,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=55|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr10:61715859..61715869,+|id=chr10:61715859..61715869,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002369!9.88e-62!7;UBERON:0006858!9.88e-62!7;UBERON:0002342!3.14e-43!10;UBERON:0005062!3.14e-43!10;UBERON:0003064!7.13e-31!14;UBERON:0005157!6.09e-16!27;UBERON:0005256!4.86e-09!47;UBERON:0005172!1.17e-08!49;UBERON:0005173!1.17e-08!49;UBERON:0002417!1.17e-08!49;UBERON:0000916!1.17e-08!49;UBERON:0002368!5.31e-07!60|ontology_enrichment_uberon_v019_2=UBERON:0002369,2.40e-74,7;UBERON:0006858,2.40e-74,7;UBERON:0003064,1.49e-37,14;UBERON:0005256,4.78e-12,45;UBERON:0005172,4.27e-11,49;UBERON:0005173,4.27e-11,49;UBERON:0002417,4.27e-11,49;UBERON:0000916,4.27e-11,49;UBERON:0002368,3.96e-09,60;UBERON:0003104,5.52e-09,61;UBERON:0009142,5.52e-09,61;UBERON:0002530,1.88e-08,65;UBERON:0009569,2.50e-08,66;UBERON:0000949,1.17e-07,72;UBERON:0005177,5.28e-07,79|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.17008658030214,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.63286352971307,0.520455980298408,1.82679286987285,3.92046345335299,3.3158980921577,3.29248379979973,8.04266184509923,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.209088296014469,0,0,0,0,0,0,0,0,0,0.194451188344048,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr10:61715859..61715869,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=55 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr10:61715859..61715869,+ | |||
|description=CAGE_peak_at_chr10:61715859..61715869,+ | |||
|id=chr10:61715859..61715869,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002369!9.88e-62!7;UBERON:0006858!9.88e-62!7;UBERON:0002342!3.14e-43!10;UBERON:0005062!3.14e-43!10;UBERON:0003064!7.13e-31!14;UBERON:0005157!6.09e-16!27;UBERON:0005256!4.86e-09!47;UBERON:0005172!1.17e-08!49;UBERON:0005173!1.17e-08!49;UBERON:0002417!1.17e-08!49;UBERON:0000916!1.17e-08!49;UBERON:0002368!5.31e-07!60 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002369,2.40e-74,7;UBERON:0006858,2.40e-74,7;UBERON:0003064,1.49e-37,14;UBERON:0005256,4.78e-12,45;UBERON:0005172,4.27e-11,49;UBERON:0005173,4.27e-11,49;UBERON:0002417,4.27e-11,49;UBERON:0000916,4.27e-11,49;UBERON:0002368,3.96e-09,60;UBERON:0003104,5.52e-09,61;UBERON:0009142,5.52e-09,61;UBERON:0002530,1.88e-08,65;UBERON:0009569,2.50e-08,66;UBERON:0000949,1.17e-07,72;UBERON:0005177,5.28e-07,79 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.17008658030214,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.63286352971307,0.520455980298408,1.82679286987285,3.92046345335299,3.3158980921577,3.29248379979973,8.04266184509923,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.209088296014469,0,0,0,0,0,0,0,0,0,0.194451188344048,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr10:61715859..61715869,+ | |||
}} |
Latest revision as of 13:37, 4 August 2015
Short description: | p@chr10:61715859..61715869, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr10:61715859..61715869, + |
Coexpression cluster: | MCL_coexpression_mm9:55 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
adrenal gland | 2.40e-74 | 7 |
adrenal/interrenal gland | 2.40e-74 | 7 |
intermediate mesoderm | 1.49e-37 | 14 |
trunk mesenchyme | 4.78e-12 | 45 |
abdomen element | 4.27e-11 | 49 |
abdominal segment element | 4.27e-11 | 49 |
abdominal segment of trunk | 4.27e-11 | 49 |
abdomen | 4.27e-11 | 49 |
endocrine gland | 3.96e-09 | 60 |
mesenchyme | 5.52e-09 | 61 |
entire embryonic mesenchyme | 5.52e-09 | 61 |
gland | 1.88e-08 | 65 |
subdivision of trunk | 2.50e-08 | 66 |
endocrine system | 1.17e-07 | 72 |
trunk region element | 5.28e-07 | 79 |